ENTITY

Therapix Biosciences (TRPX US)

Analysis

Health Care • United States

Therapix Biosciences Ltd provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. Therapix Biosciences serves customers worldwide.

Refresh

No events found

We’ll display events we find for Therapix Biosciences here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00